Catalytic Asymmetric Total Synthesis of Leucinostatin A

Chem Rec. 2021 Jan;21(1):175-187. doi: 10.1002/tcr.202000108. Epub 2020 Oct 27.

Abstract

This review describes our efforts toward achieving catalytic asymmetric total synthesis of leucinostatin A, a compound that interferes with the tumor-stroma interaction. The synthesis utilizes four catalytic asymmetric reactions, including direct-type reactions exemplified by high atom-economy, and three C-C bond forming reactions. Thorough analysis of the NMR data, HPLC profiles, and biologic activity led us to unambiguously revise the absolute configuration regarding the 6-position of the AHMOD residue side chain from S (reported) to R. Other examples of previously reported important studies on the stereoselective synthesis of HyLeu and AHMOD are also described.

Keywords: Antitumor agent; Catalytic asymmetric reaction; Structure-activity relationship; Total synthesis; Tumor-stroma interaction.

Publication types

  • Review

MeSH terms

  • Antimicrobial Cationic Peptides / chemical synthesis*
  • Antimicrobial Cationic Peptides / pharmacology
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Catalysis
  • Cell Line, Tumor
  • Humans
  • Stereoisomerism

Substances

  • Antimicrobial Cationic Peptides
  • Antineoplastic Agents
  • leucinostatin A